{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:17:53Z","timestamp":1767665873287,"version":"3.32.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":5509,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1017\/s1041610209990664","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T09:14:41Z","timestamp":1248686081000},"page":"1127-1133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Ahmet Turan","family":"Isik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ergun","family":"Bozoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610209990664_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","article-title":"Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques","volume":"263","author":"Bernstein","year":"1999","journal-title":"Neuroscience Letters"},{"key":"10.1017\/S1041610209990664_bb0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0169-328X(00)00019-X","article-title":"Altered phosphofructokinase mRNA levels but unchanged isoenzyme pattern in brains from patients with Alzheimer's disease","volume":"76","author":"Bigl","year":"2000","journal-title":"Molecular Brain Research"},{"key":"10.1017\/S1041610209990664_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00702-002-0772-x","article-title":"Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology","volume":"110","author":"Bigl","year":"2003","journal-title":"Journal of Neural Transmission"},{"key":"10.1017\/S1041610209990664_bb0025","series-title":"Alzheimer's Disease and Related Disorders Annual","first-page":"111","author":"Craft","year":"2006"},{"key":"10.1017\/S1041610209990664_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1176\/appi.ajp.161.3.532","article-title":"Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease","volume":"161","author":"Cummings","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610209990664_bb0035","first-page":"RA214","article-title":"Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation","volume":"13","author":"Das","year":"2007","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"key":"10.1017\/S1041610209990664_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuro.2007.11.004","article-title":"Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells","volume":"29","author":"Ezoulin","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1017\/S1041610209990664_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/diacare.24.2.245","article-title":"Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance","volume":"24","author":"Ferrara","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1017\/S1041610209990664_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"Journal of Neural Transmission"},{"key":"10.1017\/S1041610209990664_bb0055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1017\/S1041610209990664_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1463-1326.2003.00253.x","article-title":"Detection of insulin resistance in Turkish adults: a hospital-based study","volume":"5","author":"Gokcel","year":"2003","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1017\/S1041610209990664_bb0065","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB Journal"},{"key":"10.1017\/S1041610209990664_bb0070","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"key":"10.1017\/S1041610209990664_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","article-title":"Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis","volume":"105","author":"Hoyer","year":"1998","journal-title":"Journal of Neural Transmission"},{"key":"10.1017\/S1041610209990664_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1017\/S1041610209990664_bb0085","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S1041610207005406","article-title":"Is there any relation between insulin resistance and cognitive function in the elderly?","volume":"19","author":"Isik","year":"2007","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610209990664_bb0090","doi-asserted-by":"crossref","unstructured":"Isik A. T. , CelikT., BozogluE. and DorukH. (2009). Trospium and cognition in patients with late onset Alzheimer disease. Journal of Nutrition, Health and Aging. (In press).","DOI":"10.1007\/s12603-009-0144-4"},{"key":"10.1017\/S1041610209990664_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","article-title":"Risk of dementia among persons with diabetes mellitus: a population-based cohort study","volume":"145","author":"Leibson","year":"1997","journal-title":"American Journal of Epidemiology"},{"key":"10.1017\/S1041610209990664_bb0100","first-page":"419","article-title":"Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function","volume":"29","author":"Li","year":"2004","journal-title":"Journal of Central South University. Medical Sciences"},{"key":"10.1017\/S1041610209990664_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.69204","article-title":"The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?","volume":"11","author":"Mesulam","year":"2004","journal-title":"Learning and Memory"},{"key":"10.1017\/S1041610209990664_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(06)70434-3","article-title":"Alzheimer's disease could be \u201ctype 3 diabetes\u201d","volume":"5","author":"Pilcher","year":"2006","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610209990664_bb0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","article-title":"Relationship between serum butyrylcholinesterase and the metabolic syndrome","volume":"38","author":"Randel","year":"2005","journal-title":"Clinical Biochemistry"},{"key":"10.1017\/S1041610209990664_bb0120","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0002-9440(10)63774-1","article-title":"Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss","volume":"164","author":"Reyes","year":"2004","journal-title":"American Journal of Pathology"},{"key":"10.1017\/S1041610209990664_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-0404.2000.00310.x","article-title":"Galantamine is an allosterically potentiating ligand of the human alpha4\/beta2 nAChR","volume":"176","author":"Samochocki","year":"2000","journal-title":"Acta Neurologica Scandinavica."},{"key":"10.1017\/S1041610209990664_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-5-1","article-title":"Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies","volume":"5","author":"Sharma","year":"2006","journal-title":"Lipids in Health and Disease"},{"key":"10.1017\/S1041610209990664_bb0135","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2337\/diacare.20.5.792","article-title":"Insulin and cognitive function in elderly population: the Rotterdam Study","volume":"20","author":"Stolk","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1017\/S1041610209990664_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1126\/science.301.5629.40","article-title":"Neuroscience: insulin insults may spur Alzheimer's disease","volume":"301","author":"Taubes","year":"2003","journal-title":"Science"},{"key":"10.1017\/S1041610209990664_bb0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1017\/S1041610209990664_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","article-title":"The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment","volume":"17","author":"Watson","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1017\/S1041610209990664_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00002512-200421070-00004","article-title":"Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy","volume":"21","author":"Wilkinson","year":"2004","journal-title":"Drugs and Aging"},{"key":"10.1017\/S1041610209990664_bb0160","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"Yaffe","year":"2004","journal-title":"JAMA"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224026152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224026152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610209990664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T07:40:36Z","timestamp":1736408436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224026152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1041610224026152"],"URL":"https:\/\/doi.org\/10.1017\/s1041610209990664","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610209990664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}